Geneos Therapeutics: Inovio spinoff Geneos raises another $5M to advance therapeutic cancer vaccines
The company has now raised more than $36 million since its inception.
Read full article »
Geneos is a Pennsylvania-based clinical-stage biotechnology company that researches and develops tumor neoantigen-targeted immunotherapies for the treatment of cancer.
Read more